Clinical remission of primary aggressive CD8+ cutaneous T-cell lymphoma after pralatrexate infusion.
Department of Dermatology and Cutaneous Surgery, Miller School of Medicine University of Miami, Miami, Florida2Florida Academic Dermatology Centers, Miami, Florida.
Francisco A
FA
Kerdel
Department of Dermatology and Cutaneous Surgery, Miller School of Medicine University of Miami, Miami, Florida.
Andrew Richard
AR
Styperek
Broward Health, Broward General Medical Center, Miami, Florida.
Archana
A
Maini
D000630:Aminopterin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D001707:Biopsy, Needle; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D007262:Infusions, Intravenous; D016410:Lymphoma, T-Cell, Cutaneous / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology*; D013997:Time Factors; D016896:Treatment Outcome
C418863:10-propargyl-10-deazaaminopterin; D000630:Aminopterin